Drug Manufacturers - Specialty & Generic
Compare Stocks
4 / 10Stock Comparison
YCBD vs BYFC vs TLRY vs CARV
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Drug Manufacturers - Specialty & Generic
Banks - Regional
YCBD vs BYFC vs TLRY vs CARV — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Banks - Regional | Drug Manufacturers - Specialty & Generic | Banks - Regional |
| Market Cap | $8M | $91M | $648M | $9M |
| Revenue (TTM) | $19M | $63M | $1.17B | $37M |
| Net Income (TTM) | $-328M | $-25M | $-2.95B | $-13M |
| Gross Margin | 59.8% | 51.9% | 28.0% | 56.3% |
| Operating Margin | -5.7% | -38.8% | -266.0% | -36.8% |
| Total Debt | $778M | $153M | $451M | $29M |
| Cash & Equiv. | $2M | $11M | $304M | $50M |
YCBD vs BYFC vs TLRY vs CARV — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| cbdMD, Inc. (YCBD) | 100 | 0.2 | -99.8% |
| Broadway Financial … (BYFC) | 100 | 85.1 | -14.9% |
| Tilray Brands, Inc. (TLRY) | 100 | 56.4 | -43.6% |
| Carver Bancorp, Inc. (CARV) | 100 | 92.7 | -7.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: YCBD vs BYFC vs TLRY vs CARV
Each card shows where this stock fits in a portfolio — not just who wins on paper.
YCBD is the clearest fit if your priority is quality.
- -6.5% margin vs TLRY's -252.6%
BYFC has the current edge in this matchup, primarily because of its strength in income & stability and long-term compounding.
- Dividend streak 2 yrs, beta 0.01, yield 3.6%
- -37.8% 10Y total return vs CARV's -54.2%
- Lower volatility, beta 0.01, Low D/E 58.1%, current ratio 0.03x
- Beta 0.01, yield 3.6%, current ratio 0.03x
TLRY is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 4.8%, EPS growth -6.5%, 3Y rev CAGR 12.5%
- 4.8% revenue growth vs CARV's -8.3%
- +11.6% vs YCBD's -2.3%
CARV is the clearest fit if your priority is bank quality.
- NIM 2.6% vs BYFC's 2.5%
- Better valuation composite
- -1.9% ROA vs YCBD's -27.8%, ROIC -13.0% vs -0.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 4.8% revenue growth vs CARV's -8.3% | |
| Value | Better valuation composite | |
| Quality / Margins | -6.5% margin vs TLRY's -252.6% | |
| Stability / Safety | Beta 0.01 vs TLRY's 2.04 | |
| Dividends | 3.6% yield; 2-year raise streak; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | +11.6% vs YCBD's -2.3% | |
| Efficiency (ROA) | -1.9% ROA vs YCBD's -27.8%, ROIC -13.0% vs -0.4% |
YCBD vs BYFC vs TLRY vs CARV — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
YCBD vs BYFC vs TLRY vs CARV — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
BYFC leads in 2 of 6 categories
YCBD leads 1 • CARV leads 1 • TLRY leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
YCBD leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
TLRY is the larger business by revenue, generating $1.2B annually — 62.2x YCBD's $19M. Profitability is closely matched — net margins range from -6.5% (YCBD) to -2.5% (TLRY). On growth, YCBD holds the edge at +980.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $19M | $63M | $1.2B | $37M |
| EBITDAEarnings before interest/tax | -$286M | -$24M | -$3.0B | -$10M |
| Net IncomeAfter-tax profit | -$328M | -$25M | -$2.9B | -$13M |
| Free Cash FlowCash after capex | -$853M | -$13,000 | -$94M | -$9M |
| Gross MarginGross profit ÷ Revenue | +59.8% | +51.9% | +28.0% | +56.3% |
| Operating MarginEBIT ÷ Revenue | -5.7% | -38.8% | -2.7% | -36.8% |
| Net MarginNet income ÷ Revenue | -6.5% | -39.3% | -2.5% | -36.8% |
| FCF MarginFCF ÷ Revenue | -16.9% | -0.0% | -8.1% | -34.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +980.1% | — | +3.0% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +83.6% | -46.8% | +70.7% | -12.2% |
Valuation Metrics
Evenly matched — BYFC and TLRY and CARV each lead in 1 of 3 comparable metrics.
Valuation Metrics
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $8M | $91M | $648M | $9M |
| Enterprise ValueMkt cap + debt − cash | $784M | $233M | $795M | -$12M |
| Trailing P/EPrice ÷ TTM EPS | -0.77x | -3.03x | -0.16x | -0.62x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | — | — | — |
| Price / SalesMarket cap ÷ Revenue | 0.44x | 1.45x | 0.57x | 0.23x |
| Price / BookPrice ÷ Book value/share | 0.47x | 0.32x | 0.24x | 0.29x |
| Price / FCFMarket cap ÷ FCF | — | — | — | — |
Profitability & Efficiency
CARV leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
YCBD delivers a -3.6% return on equity — every $100 of shareholder capital generates $-4 in annual profit, vs $-137 for TLRY. TLRY carries lower financial leverage with a 0.22x debt-to-equity ratio, signaling a more conservative balance sheet compared to YCBD's 107.70x. On the Piotroski fundamental quality scale (0–9), YCBD scores 5/9 vs CARV's 2/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -3.6% | -9.1% | -136.5% | -48.4% |
| ROA (TTM)Return on assets | -27.8% | -1.9% | -100.6% | -1.9% |
| ROICReturn on invested capital | -0.4% | -3.7% | -66.2% | -13.0% |
| ROCEReturn on capital employed | -47.1% | -5.6% | -78.1% | -15.4% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 | 4 | 2 |
| Debt / EquityFinancial leverage | 107.70x | 0.58x | 0.22x | 0.98x |
| Net DebtTotal debt minus cash | $776M | $142M | $147M | -$21M |
| Cash & Equiv.Liquid assets | $2M | $11M | $304M | $50M |
| Total DebtShort + long-term debt | $778M | $153M | $451M | $29M |
| Interest CoverageEBIT ÷ Interest expense | — | -0.87x | -89.43x | -0.71x |
Total Returns (Dividends Reinvested)
Evenly matched — BYFC and TLRY each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BYFC five years ago would be worth $6,806 today (with dividends reinvested), compared to $7 for YCBD. Over the past 12 months, TLRY leads with a +1157.1% total return vs YCBD's -2.3%. The 3-year compound annual growth rate (CAGR) favors TLRY at 26.0% vs YCBD's -62.8% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -27.6% | +28.8% | -42.8% | +17.9% |
| 1-Year ReturnPast 12 months | -2.3% | +52.9% | +1157.1% | +21.3% |
| 3-Year ReturnCumulative with dividends | -94.9% | +30.3% | +100.0% | -61.8% |
| 5-Year ReturnCumulative with dividends | -99.9% | -31.9% | -63.0% | -79.2% |
| 10-Year ReturnCumulative with dividends | -100.0% | -37.8% | -75.2% | -54.2% |
| CAGR (3Y)Annualised 3-year return | -62.8% | +9.2% | +26.0% | -27.4% |
Risk & Volatility
BYFC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
BYFC is the less volatile stock with a 0.01 beta — it tends to amplify market swings less than TLRY's 2.04 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BYFC currently trades 99.4% from its 52-week high vs YCBD's 32.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.68x | 0.01x | 2.04x | 0.16x |
| 52-Week HighHighest price in past year | $2.56 | $9.86 | $15.70 | $3.85 |
| 52-Week LowLowest price in past year | $0.47 | $5.60 | $0.35 | $1.07 |
| % of 52W HighCurrent price vs 52-week peak | +32.8% | +99.4% | +35.4% | +42.9% |
| RSI (14)Momentum oscillator 0–100 | 49.1 | 80.3 | 36.8 | 51.2 |
| Avg Volume (50D)Average daily shares traded | 1.7M | 3K | 4.7M | 4K |
Analyst Outlook
BYFC leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
BYFC is the only dividend payer here at 3.55% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Hold | — |
| Price TargetConsensus 12-month target | — | — | $10.00 | — |
| # AnalystsCovering analysts | — | — | 20 | — |
| Dividend YieldAnnual dividend ÷ price | — | +3.6% | — | — |
| Dividend StreakConsecutive years of raises | 0 | 2 | — | 0 |
| Dividend / ShareAnnual DPS | — | $0.35 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% |
BYFC leads in 2 of 6 categories (Risk & Volatility, Analyst Outlook). YCBD leads in 1 (Income & Cash Flow). 2 tied.
YCBD vs BYFC vs TLRY vs CARV: Key Questions Answered
8 questions · data-driven answers · updated daily
01Is YCBD or BYFC or TLRY or CARV a better buy right now?
For growth investors, Tilray Brands, Inc.
(TLRY) is the stronger pick with 4. 8% revenue growth year-over-year, versus -8. 3% for Carver Bancorp, Inc. (CARV). Analysts rate Tilray Brands, Inc. (TLRY) a "Hold" — based on 20 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — YCBD or BYFC or TLRY or CARV?
Over the past 5 years, Broadway Financial Corporation (BYFC) delivered a total return of -31.
9%, compared to -99. 9% for cbdMD, Inc. (YCBD). Over 10 years, the gap is even starker: BYFC returned -37. 8% versus YCBD's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — YCBD or BYFC or TLRY or CARV?
By beta (market sensitivity over 5 years), Broadway Financial Corporation (BYFC) is the lower-risk stock at 0.
01β versus Tilray Brands, Inc. 's 2. 04β — meaning TLRY is approximately 24441% more volatile than BYFC relative to the S&P 500. On balance sheet safety, Tilray Brands, Inc. (TLRY) carries a lower debt/equity ratio of 22% versus 108% for cbdMD, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — YCBD or BYFC or TLRY or CARV?
By revenue growth (latest reported year), Tilray Brands, Inc.
(TLRY) is pulling ahead at 4. 8% versus -8. 3% for Carver Bancorp, Inc. (CARV). On earnings-per-share growth, the picture is similar: cbdMD, Inc. grew EPS 39. 1% year-over-year, compared to -81. 8% for Broadway Financial Corporation. Over a 3-year CAGR, TLRY leads at 12. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — YCBD or BYFC or TLRY or CARV?
cbdMD, Inc.
(YCBD) is the more profitable company, earning -10. 6% net margin versus -266. 3% for Tilray Brands, Inc. — meaning it keeps -10. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: YCBD leads at -11. 3% versus -277. 9% for TLRY. At the gross margin level — before operating expenses — YCBD leads at 56. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — YCBD or BYFC or TLRY or CARV?
In this comparison, BYFC (3.
6% yield) pays a dividend. YCBD, TLRY, CARV do not pay a meaningful dividend and should not be held primarily for income.
07Is YCBD or BYFC or TLRY or CARV better for a retirement portfolio?
For long-horizon retirement investors, Broadway Financial Corporation (BYFC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
01), 3. 6% yield). Tilray Brands, Inc. (TLRY) carries a higher beta of 2. 04 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BYFC: -37. 8%, TLRY: -75. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between YCBD and BYFC and TLRY and CARV?
These companies operate in different sectors (YCBD (Healthcare) and BYFC (Financial Services) and TLRY (Healthcare) and CARV (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: YCBD is a small-cap quality compounder stock; BYFC is a small-cap income-oriented stock; TLRY is a small-cap quality compounder stock; CARV is a small-cap quality compounder stock. BYFC pays a dividend while YCBD, TLRY, CARV do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.